Plerixafor
Back to searchMolecule Structure
Scientific Name
Plerixafor
Description of the Drug
Plerixafor is a selective chemokine receptor (CXCR4) antagonist used with filgrastim to mobilize hematopoietic stem cells to the peripheral blood for collection and autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06809
http://www.drugbank.ca/drugs/DB06809
Brand Name(s)
Mozobil
Company Owner(s)
Genzyme Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
C-X-C chemokine receptor type 4 | SINGLE PROTEIN | PARTIAL AGONIST | CHEMBL2107 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL19038 | |
PharmGKB | PA165958410 | |
Human Metabolome Database | HMDB0015681 | |
DrugBank | DB06809 | |
PubChem: Thomson Pharma | 14933416 | |
PubChem | 65015 | |
LINCS | LSM-36826 | |
Nikkaji | J579.015H | |
BindingDB | 50035696 | |
EPA CompTox Dashboard | DTXSID70869520 | |
DrugCentral | 4410 | |
ChemicalBook | CB11011749 | |
Guide to Pharmacology | 844 | |
rxnorm | MOZOBIL | PLERIXAFOR |
ChEBI | 125354 | |
ZINC | ZINC000022443609 |